News
Stericycle, MarineMax, Agios Pharmaceuticals And Other Big Stocks Moving Higher On Monday
3 Jun 24
News, Intraday Update, Markets, Movers, Trading Ideas
Denali Therapeutics Says FDA Has Selected DNL126 For Participation In Support For Clinical Trials Advancing Rare Disease Therapeutics Pilot Program
3 Jun 24
News, FDA
Louisiana-Pacific Posts Upbeat Results, Joins Cricut, Elanco Animal, American Public Education And Other Big Stocks Moving Higher On Wednesday
8 May 24
News, Intraday Update, Markets, Movers
Wedbush Maintains Outperform on Denali Therapeutics, Lowers Price Target to $30
8 May 24
News, Price Target, Analyst Ratings
Stifel Maintains Hold on Denali Therapeutics, Lowers Price Target to $22
8 May 24
News, Price Target, Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Denali Therapeutics, Maintains $95 Price Target
8 May 24
News, Price Target, Reiteration, Analyst Ratings
Denali Therapeutics Q1 EPS $(0.68) Beats $(0.70) Estimate
7 May 24
Earnings, Earnings Beats, News
UBS Maintains Buy on Denali Therapeutics, Lowers Price Target to $32
9 Apr 24
News, Price Target, Analyst Ratings
Press releases
Flagship Pioneering and ProFound Therapeutics Announce Agreement to Identify Novel First-in-Class Therapeutics for the Treatment of Obesity under Strategic Partnership with Pfizer
12 Jun 24
Press Releases
Denali Therapeutics Announces FDA Has Selected DNL126 (ETV:SGSH) for MPS IIIA (Sanfilippo Syndrome Type A) for START Pilot Program Intended to Accelerate Development of Rare Disease Therapies
3 Jun 24
Health Care, Press Releases
Denali Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
7 May 24
Earnings, Press Releases
Flagship Pioneering Unveils Prologue Medicines to Unlock the Therapeutic Potential of the Viral Proteome
7 May 24
Press Releases
Flagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences
8 Apr 24
Press Releases